Señales en vivo de OBMP | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products...

Stats
Volumen de hoy	58 992.00
Volumen promedio	8 379.00
Capitalización de mercado	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2020-09-24	Chilcott, Iii Thomas E.	Buy	0
2020-06-05	Ruxin Michael I	Buy	0
2020-05-07	Head Jonathan Frederick	Buy	166 667	Shares of Common Stock
2019-04-24	Holcomb Robert Neal	Buy	3 000 000	Employee Stock Option (right to buy)
2019-04-24	Hoverman Daniel S.	Buy	3 000 000	Employee Stock Option (right to buy)

INSIDER POWER
0.00
Last 25 transactions
Buy: 69 901 401 \| Sell: 14 397 245

Theralink Technologies, Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Theralink Technologies, Finanzas

Annual	2021
Ingresos:	$505 604
Beneficio Bruto:	$388 148 (76.77 %)
EPS:	$-0.00124

FY	2021
Ingresos:	$505 604
Beneficio Bruto:	$388 148 (76.77 %)
EPS:	$-0.00124

FY	2020
Ingresos:	$181 229
Beneficio Bruto:	$128 642 (70.98 %)
EPS:	$-0.0374

FY	2019
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-19.00

Financial Reports:

No articles found.

Theralink Technologies,

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.